Confocal Raman microspectroscopy for spatially resolved tissue characterisation of disease-linked spectra-pathological signatures
Nektarios A. Valous , Inka Zörnig , Dirk Jäger
Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (10) : e70487
Confocal Raman microspectroscopy for spatially resolved tissue characterisation of disease-linked spectra-pathological signatures
Raman spectroscopy is a versatile analytical technique for highly specific molecular characterisation of cells, biofluids and tissues. Confocal Raman microspectroscopy combines optical microscopy with Raman spectroscopy to spatially resolve biochemical changes in tissue samples. This work focuses on research articles that utilise confocal Raman microspectroscopy in human or murine tissue sections for identifying disease-linked spectra-pathological features. For scientists and clinicians who seek ideas in incorporating confocal Raman microspectroscopy into their experimental workflows, this piece provides a curated selection of studies (spanning cancer and cardiovascular diseases) that highlight key spectroscopic and biomedical insights. The lack of standardisation and the fragmentation of research protocols are major challenges that limit study reproducibility and prevent systematic cross-validation. Moving forward, confocal Raman microspectroscopy, coupled with robust computational approaches, will continue to detect disease-specific spatiotemporal biomolecular signatures, and integration with complementary imaging or omics methods will keep enhancing its ability to analyse complex biological systems and uncover disease progression mechanisms.
biochemical imaging / biophotonics / Raman microscopy / spectral analysis / tissue-level insights
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |